{"id":"W2565340265","doi":"10.1016/j.trci.2016.12.003","title":"Active Aβ immunotherapy CAD106 in Alzheimer's disease: A phase 2b study","year":2016,"lang":"en","type":"article","venue":"Alzheimer s & Dementia Translational Research & Clinical Interventions","topic":"Alzheimer's disease research and treatments","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"Novartis Pharma; Strong","keywords":"Medicine; Tolerability; Placebo; Internal medicine; Adverse effect; Adjuvant; Gastroenterology; Serology; Immunology; Antibody; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001150112,0.0009769617,0.001944192,0.0003136425,0.0003081024,0.0007037672,0.0005301433,0.0009944456,0.003120468],"category_scores_gemma":[0.0004107131,0.0002957667,0.0007907991,0.0002561204,0.000380919,0.0003141072,0.0001821695,0.001139347,0.0005952573],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002498154,"about_ca_system_score_gemma":0.0005925213,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003960791,"about_ca_topic_score_gemma":0.000672865,"domain_scores_codex":[0.9997349,0.0001181348,0.00002129583,0.00004656165,0.00003397925,0.00004510001],"domain_scores_gemma":[0.9996843,0.00005282212,0.00006671237,0.00002158347,0.00003067044,0.00014396],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8271136,0.04183884,0.005941764,0.001670006,0.00194124,0.0002849003,0.0001044087,0.0005066322,0.04373127,0.0001348911,0.002150093,0.07458228],"study_design_scores_gemma":[0.770714,0.210662,0.01415001,0.00004945983,0.0005724343,0.0001591185,0.00001913746,0.0003001692,0.001623026,0.00006097872,0.001670263,0.00001961585],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9913638,0.005146259,0.0003311543,0.0002254491,0.0001158926,0.00135885,0.0005712926,0.00006082897,0.0008264389],"genre_scores_gemma":[0.9895935,0.003225676,0.001056334,0.0008406691,0.0003097345,0.001611499,0.001486112,0.00001135914,0.001865112],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003120468,"threshold_uncertainty_score":0.01043904,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3190082853627753,"score_gpt":0.5553090210123203,"score_spread":0.236300735649545,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}